Literature DB >> 66677

Identification of simian virus 40 tumor and U antigens.

J A Robb.   

Abstract

The synthesis and identity of the tumor and U antigens of simian virus 40 (SV 40) have been examined during productive infection in monkey cells, abortive infection in mouse cells, and in SV40-transformed mouse cells by using sodium dodecyl sulfate/polyacrylamide slab gel electrophoresis to analyze [35S]methionine-labeled radioimmune precipitates. The following observations were made: (i) the tumor and U antigenic sites are on the same 94,000, 89,000, and 84,000 molecular weight species detected during productive infection; a 94,000 species made during abortive infection; and a 94,000 species found in transformed cells. (ii) The 94,000 species is relatively unstable compared to the relatively stable 89,000 and 84,000 species produced during productive infection. (iii) The stable 89,000 and 84,000 molecular weight species are differentially extracted from productively infected cells, which suggests an intracellular compartmentation and/or different affinities of these species for cellular substrates. (iv) The 94,000 species synthesized during abortive infection is more stable than the comparable 94,000 species synthesized in transformed cells. (v) Three tsA group mutants overproduce several unstable species of tumor antigen at restrictive temperature.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66677      PMCID: PMC392306          DOI: 10.1073/pnas.74.2.447

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Function of simian virus 40 gene A in transforming infection.

Authors:  P Tegtmeyer
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

3.  Temperature-sensitive mutants of simian virus 40 selected by transforming ability.

Authors:  N Yamaguchi; T Kuchino
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

4.  Adenovirus transcription. II. RNA sequences complementary to simian virus 40 and adenovirus 2DNA in AD2+ND1- and AD2+ND3-infected cells.

Authors:  S J Flint; Y Wewerka-Lutz; A S Levine; J Sambrook; P A Sharp
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

5.  DNA infectivity and the induction of host DNA synthesis with temperature-sensitive mutants of simian virus 40.

Authors:  J Y Chou; R G Martin
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

6.  Regulation of tumor antigen synthesis by simain virus 40 gene A.

Authors:  P Tegtmeyer; M Schwartz; J K Collins; K Rundell
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

7.  Simian virus 40 functions required for the establishment and maintenance of malignant transformation.

Authors:  R G Martin; J Y Chou
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

8.  Role of simian virus 40 gene A function in maintenance of transformation.

Authors:  J S Brugge; J S Butel
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

9.  Simian virus 40 gene A function and maintenance of transformation.

Authors:  M Osborn; K Weber
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

10.  DIFFERENTIAL EFFECTS OF INHIBITORS ON THE STEPS LEADING TO THE FORMATION OF SV40 TUMOR AND VIRUS ANTIGENS.

Authors:  F RAPP; J S BUTEL; L A FELDMAN; T KITAHARA; J L MELNICK
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

View more
  10 in total

1.  Simian virus 40-specific proteins in the membranes of simian virus 40-transformed hamster and mouse cells.

Authors:  R Schmidt-Ullrich; W S Thompson; P S Lin; D F Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

2.  Nucleotide sequence of the simian virus 40 small-t gene.

Authors:  G Volckaert; A Van de Voorde; W Fiers
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Extraction and fingerprint analysis of simian virus 40 large and small T-antigens.

Authors:  A E Smith; R Smith; E Paucha
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

4.  Association of simian virus 40 T antigen with replicating nucleoprotein complexes of simian virus 40.

Authors:  M Segawa; S Sugano; N Yamaguchi
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

5.  Transformation by simian virus 40 induces virus-specific, related antigens in the surface membrane and nuclear envelope.

Authors:  P S Lin; R Schmidt-Ullrich; D F Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

6.  Monoclonal antibodies against simian virus 40 tumor antigens: analysis of antigenic binding sites, using adenovirus type 2-simian virus 40 hybrid viruses.

Authors:  W Deppert; E G Gurney; R O Harrison
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

7.  Pathogenic murine coronaviruses. II. Characterization of virus-specific proteins of murine coronaviruses JHMV and A59V.

Authors:  C W Bond; J L Leibowitz; J A Robb
Journal:  Virology       Date:  1979-04-30       Impact factor: 3.616

8.  Tumor-specific transplantation antigen: use of the Ad2+ND1 hybrid virus to identify the protein responsible for simian virus 40 tumor rejection and its genetic origin.

Authors:  G Jay; F T Jay; C Chang; R M Friedman; A S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Simian virus 40 T- and U-antigens: immunological characterization and localization in different nuclear subfractions of simian virus 40-transformed cells.

Authors:  W Deppert
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.